• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层视角下的罕见病患者管理:以喀麦隆为例看患者组织在全球罕见病认可中的作用。

The management of rare disease patients from a grassroot perspective: the role of patients' organizations in the global recognition of rare diseases in Cameroon.

机构信息

Department of Sociology, University of Yaounde I, Yaounde, Cameroon.

出版信息

Pan Afr Med J. 2024 Feb 13;47:64. doi: 10.11604/pamj.2024.47.64.38226. eCollection 2024.

DOI:10.11604/pamj.2024.47.64.38226
PMID:38681114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11055193/
Abstract

INTRODUCTION

rare diseases (RD) are extremely complex health conditions. Persons affected by these conditions in Cameroon are often neglected in society and health systems through the inexistence of policies and programs. In Cameroon, there exists no program or policy conceived to address their needs in terms of access to quality health care, timely and reliable diagnosis, treatments, education, etc. The consequence is that persons living with a RD (PLWRD) and their families do not participate in social life. The unique fate of PLWRD reveals that the principle of social justice and equity is flawed in Cameroon. However, patients, in order to survive in society, rely on patients' organizations (PO) to improve their quality of life (QoL) and advocate for a better consideration in the society. The aim of this paper is to highlight how initiatives from a grassroot perspective like POs can inform decision-makers to address the needs of PLWRD and their families.

METHODS

the study associated a systematic literature review and semi-structured interviews with parents of children suffering from a RD and who are members of a PO. Through the systematic literature review we highlighted the impact POs have in the development of research on RDs, patient literacy, patient empowerment and advocacy while semi-structured interviews brought out the needs of patients and their families.

RESULTS

findings, on the one hand show that, in Cameroon PLWRD face a number of challenges like the incurability of their condition, catastrophic medical expenses, stigmatization and marginalization, etc. and though in POs their QoL still remains poor. On the other hand, where POs are empowered they are key actors in research on RDs and help decision-makers on having a better insight into the type of RD that exists across a geographical area, the sociodemographic profile of patients, etc. for a better management of PLWRD.

CONCLUSION

the study suggests that the ministry of public health should create a network with existing RD POs to adequately meet the needs of PLWRD.

摘要

简介

罕见病(RD)是极其复杂的健康状况。在喀麦隆,受这些疾病影响的人在社会和卫生系统中经常被忽视,因为没有相关政策和计划。在喀麦隆,没有针对他们获得高质量医疗保健、及时可靠诊断、治疗、教育等需求的方案或政策。其结果是,患有 RD 的人(PLWRD)及其家属无法参与社会生活。PLWRD 的独特命运表明,喀麦隆的社会正义和平等原则存在缺陷。然而,为了在社会中生存,患者依赖于患者组织(PO)来提高他们的生活质量(QoL)并倡导在社会中得到更好的考虑。本文的目的是强调像 PO 这样的基层倡议如何为决策者提供信息,以满足 PLWRD 及其家属的需求。

方法

本研究结合了系统文献综述和对患有 RD 且是 PO 成员的儿童家长的半结构式访谈。通过系统文献综述,我们强调了 PO 在 RD 研究、患者素养、患者赋权和倡导方面的发展所产生的影响,而半结构式访谈则揭示了患者及其家属的需求。

结果

一方面,研究结果表明,在喀麦隆,PLWRD 面临着许多挑战,例如病情无法治愈、医疗费用高昂、污名化和边缘化等,尽管在 PO 中,他们的生活质量仍然很差。另一方面,在 PO 被赋予权力的地方,他们是 RD 研究的关键参与者,并帮助决策者更好地了解地理区域内存在的 RD 类型、患者的社会人口特征等,以更好地管理 PLWRD。

结论

研究表明,公共卫生部应与现有的 RD PO 建立网络,以充分满足 PLWRD 的需求。

相似文献

1
The management of rare disease patients from a grassroot perspective: the role of patients' organizations in the global recognition of rare diseases in Cameroon.基层视角下的罕见病患者管理:以喀麦隆为例看患者组织在全球罕见病认可中的作用。
Pan Afr Med J. 2024 Feb 13;47:64. doi: 10.11604/pamj.2024.47.64.38226. eCollection 2024.
2
Impact of mental health in persons living with rare disease: Findings from the AMCP Market Insights Program.精神健康对罕见病患者的影响:来自 AMCP 市场洞察计划的研究结果。
J Manag Care Spec Pharm. 2024 Jul;30(7-b Suppl):S1-S11. doi: 10.18553/jmcp.2024.30.7-b.s1.
3
Living with a rare disease - experiences and needs in pediatric patients and their parents.与罕见病共存——儿科患者及其父母的经历和需求。
Orphanet J Rare Dis. 2023 Aug 11;18(1):242. doi: 10.1186/s13023-023-02837-9.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
The role of patient organizations in the rare disease ecosystem in India: an interview based study.患者组织在印度罕见病生态系统中的作用:基于访谈的研究。
Orphanet J Rare Dis. 2019 May 29;14(1):117. doi: 10.1186/s13023-019-1093-6.
6
Patient empowerment of people living with rare diseases. Its contribution to sustainable and resilient healthcare systems.罕见病患者赋权。对可持续和有弹性的医疗保健系统的贡献。
Ann Ist Super Sanita. 2019 Jul-Sep;55(3):283-291. doi: 10.4415/ANN_19_03_15.
7
Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey.罕见病患者的诊断时间和诊断延迟的决定因素:罕见病晴雨表回顾性患者调查结果。
Eur J Hum Genet. 2024 Sep;32(9):1116-1126. doi: 10.1038/s41431-024-01604-z. Epub 2024 May 16.
8
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
9
Rare disease emerging as a global public health priority.罕见病成为全球公共卫生重点关注对象。
Front Public Health. 2022 Oct 18;10:1028545. doi: 10.3389/fpubh.2022.1028545. eCollection 2022.
10
Type 1 diabetes care delivery in Yaoundé, Cameroon: Social and political representations.喀麦隆雅温得 1 型糖尿病护理服务提供情况:社会和政治代表性研究。
Afr J Prim Health Care Fam Med. 2024 Mar 15;16(1):e1-e16. doi: 10.4102/phcfm.v16i1.4229.

引用本文的文献

1
The impact of rare diseases on the quality of life in paediatric patients: current status.罕见病对儿科患者生活质量的影响:现状
Front Public Health. 2025 Mar 24;13:1531583. doi: 10.3389/fpubh.2025.1531583. eCollection 2025.

本文引用的文献

1
Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases.常见条件下的罕见需求:一项定性研究,旨在探索罕见病儿科患者的护理需求。
Orphanet J Rare Dis. 2022 Apr 4;17(1):153. doi: 10.1186/s13023-022-02305-w.
2
Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations.患者组织与临床研究赞助商在罕见病情况下的合作:从社区咨询委员会获得的经验教训和未来合作的最佳实践。
BMJ Open. 2020 Dec 16;10(12):e039473. doi: 10.1136/bmjopen-2020-039473.
3
Patients' organizations in rare diseases and involvement in drug information: Illustrations with LMC France, the French Association of Chronic Myeloid leukemia.罕见病患者组织与药品信息参与:以法国慢性髓性白血病协会(LMC France)为例
Therapie. 2020 Apr;75(2):221-224. doi: 10.1016/j.therap.2020.02.014. Epub 2020 Feb 13.
4
Patient empowerment of people living with rare diseases. Its contribution to sustainable and resilient healthcare systems.罕见病患者赋权。对可持续和有弹性的医疗保健系统的贡献。
Ann Ist Super Sanita. 2019 Jul-Sep;55(3):283-291. doi: 10.4415/ANN_19_03_15.
5
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.估算罕见病的累计点患病率:对孤儿药数据库的分析。
Eur J Hum Genet. 2020 Feb;28(2):165-173. doi: 10.1038/s41431-019-0508-0. Epub 2019 Sep 16.
6
From the day they are born: a qualitative study exploring violence against children with disabilities in West Africa.从出生之日起:一项探索西非残疾儿童所受暴力问题的定性研究。
BMC Public Health. 2018 Jan 17;18(1):153. doi: 10.1186/s12889-018-5057-x.
7
Indigenous Genetics and Rare Diseases: Harmony, Diversity and Equity.原住民遗传学与罕见病:和谐、多样与公平。
Adv Exp Med Biol. 2017;1031:511-520. doi: 10.1007/978-3-319-67144-4_27.
8
The challenge and promise of rare disease diagnosis in China.中国罕见病诊断面临的挑战与机遇。
Sci China Life Sci. 2017 Jul;60(7):681-685. doi: 10.1007/s11427-017-9100-1. Epub 2017 Jun 14.
9
Rare diseases are a 'common' problem for clinicians.罕见病对临床医生来说是个“常见”问题。
Aust Fam Physician. 2015 Sep;44(9):630-3.
10
Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe.欧洲患者组织参与罕见病孤儿药的研发
Mol Syndromol. 2012 Nov;3(5):237-43. doi: 10.1159/000342758. Epub 2012 Sep 13.